Michelle Afkhami

1.1k total citations
58 papers, 579 citations indexed

About

Michelle Afkhami is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Michelle Afkhami has authored 58 papers receiving a total of 579 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 15 papers in Pathology and Forensic Medicine and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Michelle Afkhami's work include Acute Myeloid Leukemia Research (8 papers), Lung Cancer Treatments and Mutations (6 papers) and Cutaneous lymphoproliferative disorders research (5 papers). Michelle Afkhami is often cited by papers focused on Acute Myeloid Leukemia Research (8 papers), Lung Cancer Treatments and Mutations (6 papers) and Cutaneous lymphoproliferative disorders research (5 papers). Michelle Afkhami collaborates with scholars based in United States, Mexico and Israel. Michelle Afkhami's co-authors include Simion I. Chiosea, Yuri E. Nikiforov, Arivarasan Karunamurthy, Diana Bell, Marina N. Nikiforova, Raja R. Seethala, Christopher J. Coyne, Victoria Villaflor, Arya Amini and Rangarajan D. Nadadur and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Michelle Afkhami

47 papers receiving 573 citations

Peers

Countries citing papers authored by Michelle Afkhami

Since Specialization

Citations

This map shows the geographic impact of Michelle Afkhami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle Afkhami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle Afkhami more than expected).

Fields of papers citing papers by Michelle Afkhami

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle Afkhami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle Afkhami. The network helps show where Michelle Afkhami may publish in the future.

Co-authorship network of co-authors of Michelle Afkhami

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle Afkhami. A scholar is included among the top collaborators of Michelle Afkhami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle Afkhami. Michelle Afkhami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Solid basaloid adenoid cystic carcinoma of the breast: A high-grade triple negative breast carcinoma which rarely responds to neoadjuvant chemotherapy 2025 ·Human Pathology ·(unknown), Fang Fan, Daniel Schmolze, Javier Arias‐Stella, Leslie Taylor, (unknown), Michelle Afkhami, (unknown), Veronica Jones, (unknown), Min Han	1
2	Application of RNA-Based Next-Generation Sequencing Fusion Assay for Hematological Malignancies 2025 ·International Journal of Molecular Sciences ·Fei Fei, Milhan Telatar, (unknown), Lisa Chang, (unknown), (unknown), (unknown), Olga V. Danilova, Javier Arias‐Stella, Raju Pillai, Ibrahim Aldoss, (unknown), Pamela S. Becker, Vinod Pullarkat, Guido Marcucci, Michelle Afkhami	0
3	Pseudoglandular Schwannoma With FUS::KLF17 Fusion: Broadening the Spectrum of FUS‐Associated Tumors 2025 ·Genes Chromosomes and Cancer ·(unknown), (unknown), (unknown), Michelle Afkhami, Diana Bell	0
4	Histologic characteristics and predictors of outcome in epithelial-myoepithelial carcinoma (EMC) of salivary gland: a multi-center study of 75 cases 2025 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Bin Xu, Kartik Viswanathan, Michelle Afkhami, (unknown), (unknown), Kelly R. Magliocca, (unknown), Ronald Ghossein, (unknown), Lisa M. Rooper, Nora Katabi	0
5	Novel LZTR1 germline mutation as a mechanism of resistance to osimertinib in EGFR-mutated lung adenocarcinoma: a case report 2025 ·Translational Lung Cancer Research ·(unknown), (unknown), Isa Mambetsariev, (unknown), (unknown), (unknown), Pauline Kim, (unknown), Arya Amini, Michelle Afkhami, Ravi Salgia	2
6	The clinical utility of a circulating tumor cell based cerebrospinal fluid assay in the diagnosis and molecular analysis of leptomeningeal disease in patients with metastatic non-small cell lung cancer. 2024 ·Journal of Clinical Oncology ·Ramya Muddasani, (unknown), (unknown), Isa Mambetsariev, Erminia Massarelli, Michelle Afkhami, Ravi Salgia, Jyoti Malhotra	1
7	Conundrum of 3N: nasopharyngeal nonkeratinizing non-viral carcinoma—reappraisal of fusions and report of two consecutive cases with unusual molecular findings 2024 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Diana Bell, Michelle Afkhami	2
8	Genomic Landscape of Myelodysplastic/Myeloproliferative Neoplasms: A Multi-Central Study 2024 ·International Journal of Molecular Sciences ·Fei Fei, Amar Jariwala, Sheeja T. Pullarkat, (unknown), Yan Liu, (unknown), Haris Ali, Salman Otoukesh, Idoroenyi Amanam, Andrew Artz, (unknown), Milhan Telatar, Ryotaro Nakamura, Guido Marcucci, Michelle Afkhami	3
9	A novel HLA-DQB2::MET gene fusion variant in lung adenocarcinoma with prolonged response to tepotinib: a case report 2024 ·Translational Lung Cancer Research ·(unknown), Isa Mambetsariev, (unknown), (unknown), (unknown), (unknown), Behnam Badie, Leonidas Arvanitis, Michelle Afkhami, Miguel A. Villalona‐Calero, Ravi Salgia	0
10	Epstein-Barr virus–positive, primary cutaneous marginal zone lymphoma, with transformation: Case report and review of the literature 2024 ·American Journal of Clinical Pathology ·(unknown), (unknown), J. Reid, Winston Lee, Joo Y. Song, Michelle Afkhami, Geoffrey Shouse, Fei Fei, Olga V. Danilova, Raju Pillai, (unknown), Christiane Querfeld	0
11	Complete response to chemoimmunotherapy with bevacizumab in synchronous multiple primary cancers: pulmonary adenocarcinoma and sarcomatoid carcinoma 2023 ·Molecular Case Studies ·Diogo Moniz‐Garcia, Isa Mambetsariev, (unknown), Daniel Schmolze, Michelle Afkhami, (unknown), Pauline Kim, (unknown), (unknown), (unknown), Yuman Fong, Ravi Salgia	1
12	Complete mimicry: Rhabdomyosarcoma with FUS::TFCP2 fusion masquerading as carcinoma—diagnostic challenge and report of two cases 2023 ·Genes Chromosomes and Cancer ·(unknown), (unknown), Sue Chang, Michelle Afkhami, (unknown), Diana Bell, Javier Arias‐Stella	4
13	Preparing for the unexpected: Recommendations for returning secondary findings in late-stage cancer care 2023 ·Genetics in Medicine ·(unknown), Ilana Solomon, Sarah McGraw, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Michelle Afkhami, Janine LoBello, Szabolcs Szelinger, Stacy W. Gray	0
14	Wolf in sheep's clothing - Oral proliferative verrucous leukoplakia: Progression with longitudinal molecular insights 2023 ·Annals of Diagnostic Pathology ·Michelle Afkhami, Ellie Maghami, (unknown), Victoria Villaflor, Diana Bell	10
15	Recurrent/Metastatic Nasopharyngeal Carcinoma Treatment from Present to Future: Where Are We and Where Are We Heading? 2023 ·Current Treatment Options in Oncology ·Juan José Juárez‐Vignon Whaley, Michelle Afkhami, Mykola Onyshchenko, Erminia Massarelli, Sagus Sampath, Arya Amini, Diana Bell, Victoria Villaflor	39
16	Early Stage and Locally Advanced Nasopharyngeal Carcinoma Treatment from Present to Future: Where Are We and Where Are We Going? 2023 ·Current Treatment Options in Oncology ·Juan José Juárez‐Vignon Whaley, Michelle Afkhami, Sagus Sampath, Arya Amini, Diana Bell, Victoria Villaflor	15
17	Selpercatinib and Pralsetinib Induced Chylous Ascites in RET-Rearranged Lung Adenocarcinoma: A Case Series 2023 ·Clinical Lung Cancer ·(unknown), Joshua Wang, (unknown), Isa Mambetsariev, Pauline Kim, (unknown), Bihong T. Chen, Michelle Afkhami, Vivek Subbiah, Ravi Salgia	9
18	Heterotopic SMARCB1-deficient high-grade transformed/dedifferentiated acinic cell carcinoma and sine-qua-non radiology- pathology with TNM challenge 2022 ·Annals of Diagnostic Pathology ·Ellie Maghami, Michelle Afkhami, Victoria Villaflor, (unknown)	1
19	Papillary Thyroid Carcinoma with High-Grade Features Versus Poorly Differentiated Thyroid Carcinoma: An Analysis of Clinicopathologic and Molecular Features and Outcome 2020 ·Thyroid ·Kristine Wong, Fei Dong, Milhan Telatar, Jochen H. Lorch, Erik K. Alexander, Ellen Marqusee, Nancy L. Cho, Matthew A. Nehs, Gerard M. Doherty, Michelle Afkhami, Justine A. Barletta	51
20	Necrotizing sarcoid granulomatosis 2012 ·Current Opinion in Pulmonary Medicine ·(unknown), Michelle Afkhami, Christopher Lee, O. P. Sharma	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact